ACOG · Alpha Cognition Inc.
$8.41
-0.17 (-1.98%)
At close · Jul 28
Market Cap
$186.82M
Shares
21.77M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$10.22M
-89.8%
FY2025
Net Income
-$20.67M
-39.8%
FY2025
Gross Margin
94.1%
FY2025
Operating Margin
-221.72%
-209.7pp
FY2025
Diluted EPS
-$1.18
+42.2%
FY2025
Operating Cash Flow
-$20.38M
-162.8%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| $10.83M | $10.22M | $100M | — | |
| — | $603.4K | — | — | |
| — | $9.62M | — | — | |
| — | 94.1% | — | — | |
| $2.56M | $1.87M | $3.92M | $4.88M | |
| — | — | $7.94M | $5.05M | |
| $34.24M | $29.08M | $8.01M | — | |
| $21.55K | $21.55K | $79.88K | — | |
| — | $58.57K | $81.22K | $84.48K | |
| — | $32.88M | $12.01M | $9.94M | |
| $38.18M | $32.88M | $12.01M | — | |
| -$27.35M | -$22.66M | -$12.01M | -$9.94M | |
| — | -221.72% | -12.01% | — | |
| — | -$22.6M | -$11.93M | -$9.85M | |
| $89.96K | — | $105.27K | $17.52K | |
| — | — | $161.66K | $6804 | |
| $1.93M | $1.99M | -$2.78M | -$3.83M | |
| -$25.42M | -$20.67M | -$14.79M | -$13.76M | |
| — | -202.24% | -14.79% | — | |
| — | — | -$14.64M | -$13.78M | |
| USD/shares | — | -$1.17 | -$2.04 | -$3.84 |
| USD/shares | — | -$1.18 | -$2.04 | -$3.84 |
| shares | — | 17.68M | 7.25M | 3.59M |
| shares | — | 17.68M | 7.25M | 3.59M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 4.85×
EV/EBIT
—
Peer median 26.92×
P/E (TTM)
—
Peer median 4.83×
Peer medians compare against the 305 similar-size Biotechnology companies (of 522 listed).
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | FY2025 |
|---|---|
| United States | $6,792,024 |
| China | $3,428,251 |
By Product & Service (USD)
| Component | FY2025 |
|---|---|
| Product Net | $6,792,024 |
| License | $3,428,251 |
| Licensing | $598,430 |